EntreMed is developing vaccines for non-infectious diseases, using liposomes to deliver its antigens.
You may also be interested in...
Can "real world evidence" drive consumer health innovation? HBW Insight speaks to Orbital Research’s Chris Bunniss about RWE’s potential for the OTC industry.
Confidence in the vaccine has slipped in the US, regardless of political affiliation.
Italy's Chiesi is looking to take a slice of Poland's consumer healthcare market by acquiring infant supplements specialist Smart Pharma.